Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-02-28 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +73,720 73,720
2020-02-28 Schultz Kare President and CEO Grant or award · Restricted Share Units +260,190 260,190
2020-02-28 Sabag Mark See "Remarks" below Grant or award · Restricted Share Units +82,393 82,393
2020-02-28 O'Grady Brendan P. EVP, North America Commercial Grant or award · Restricted Share Units +99,739 99,739
2020-02-28 Nazzi Gianfranco EVP, International Markets Grant or award · Restricted Share Units +60,711 60,711
2020-02-28 Kalif Eliyahu Sharon EVP, Chief Financial Officer Grant or award · Restricted Share Units +73,720 73,720
2020-02-28 Griffin Deborah A Chief Accounting Officer Grant or award · Restricted Share Units +21,459 21,459
2020-02-28 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +86,730 86,730
2020-02-28 Drape Eric Executive VP Global Operations Grant or award · Restricted Share Units +78,057 78,057
2020-02-28 Dethlefs Sven EVP Global Marketing&Portfolio Grant or award · Restricted Share Units +69,384 69,384
2020-02-28 Daniell Richard Exec. VP, European Commercial Grant or award · Restricted Share Units +82,393 82,393
2020-02-19 Drape Eric Executive VP Global Operations Sale −8,000 $12.51 $100K 21,494
2020-02-14 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +13,090 16,064.39
2020-02-14 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +3,926 19,990.39
2020-02-14 Stark David Matthew Exec. VP Chief Legal Officer Sale −13,090 $12.14 $159K 6,900.39
2020-02-14 Stark David Matthew Exec. VP Chief Legal Officer Sale −3,926 $12.14 $48K 2,974.39
2020-02-14 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −13,090 0
2020-02-14 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −3,926 3,926
2020-02-14 Sabag Mark See "Remarks" below Option exercise +19,040 19,040
2020-02-14 Sabag Mark See "Remarks" below Option exercise +5,710 24,750

Page 58 of 76 · 1,517 trades